Anti-Saccharomyces cerevisiae antibodies in coeliac disease

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 7, 2007, Pages 821-826

  Toumi, Dorsaf ^a   Mankaï, Amani ^a   Belhadj, Ramla ^b   Ghedira Besbes, Leila ^a   Jeddi, Moncef ^a   Ghedira, Ibtissem ^a,b  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

ASCA; Coeliac disease; Gluten free diet

Indexed keywords

FUNGUS ANTIBODY; GLUTEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; ARTICLE; BLOOD DONOR; CELIAC DISEASE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTEN FREE DIET; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SACCHAROMYCES CEREVISIAE; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIBODIES, FUNGAL; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTEN; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SACCHAROMYCES CEREVISIAE;

EID: 34250190229     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520601154996     Document Type: Article

References (21)

1. Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998;42:788-91.
2. Mallant-Hent RCh, Mary B, von Blomberg E, Yuksel Z, Wahab PJ, Gundy C, et al. Disappearance of anti-Saccharomyces cerevisiae antibodies in coeliac disease during a gluten-free diet. Eur J Gastroenterol Hepatol 2006;18:75-8.
3. Granito A, Zauli D, Muratori P, Muratori L, Grassi A, Bortolotti R, et al. Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet. Aliment Pharmacol Ther 2005;21:881-7.
4. Candelli M, Nista EC, Carloni E, Pignataro G, Rigante D, Gasbarrini A. Anti-Saccharomyces cerevisiae antibodies and coeliac disease. Scand J Gastroenterol 2003;38:1191-2.
5. Damoiseaux JG, Bouten B, Linders AM, Austen J, Roozendaal C, Russel MG, et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease. J Clin Immunol 2002;22:281-8.
6. Israeli E, Grotto I, Gilburd B, Balicer RD, Goldin E, Wiik A, et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 2005;54:1232-6.
7. Granito A, Muratori L, Muratori P, Guidi M, Lenzi M, Bianchi FB, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) in coeliac disease. Gut 2006;55:296.
8. Clemente MG, De Virgiliis S, Kang JS, Macatagney R, Musu MP, Di Pierro MR, et al. Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut 2003;52:218-23.
9. Monsuur AJ, de Bakker PI, Alizadeh BZ, Zhernakova A, Bevova MR, Strengman E, et al. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 2005;37:1341-4.
10. Hunt KA, Monsuur AJ, McArdle WL, Kumar PJ, Travis SP, Walters JR, et al. Lack of association of MYO9B genetic variants with coeliac disease in a British cohort. Gut 2006;55:969-72.
11. Standaert-Vitse A, Jouault T, Vandewalle P, Mille C, Seddik M, Sendid B, et al. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. Gastroenterology 2006;130:1764-75.
12. Barclay GR, McKenzie H, Pennington J, Parratt D, Pennington CR. The effect of dietary yeast on the activity of stable chronic Crohn's disease. Scand J Gastroenterol 1992;27:196-200.
13. Nieuwenhuizen WF, Pieters RH, Knippels LM, Jansen MC, Koppelman SJ. Is Candida albicans a trigger in the onset of coeliac disease? Lancet 2003;361:2152-4.
14. Annese V, Piepoli A, Perri F, Lombardi G, Latiano A, Napolitano G, et al. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features. Aliment Pharmacol Ther 2004;20:1143-52.
15. van Elburg RM, Uil JJ, Mulder CJ, Heymans HS. Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease. Gut 1993;34:354-7.
16. Duerksen DR, Wilhelm-Boyles C, Parry DM. Intestinal permeability in long-term follow-up of patients with celiac disease on a gluten-free diet. Dig Dis Sci 2005;50:785-90.
17. Uil JJ, van Elburg RM, van Overbeek FM, Meyer JW, Mulder CJ, Heymans HS. Follow-up of treated coeliac patients: sugar absorption test and intestinal biopsies compared. Eur J Gastroenterol Hepatol 1996;8:219-23.
18. Ciacci C, Cirrillo M, Cavallaro R, Mazzacca G. Long-term follow-up of celiac adults on gluten-free diet: prevalence and correlates of intestinal damage. Digestion 2002;66:178-85.
19. Brandtzaeg P. The changing immunological paradigm in coeliac disease. Immunol Lett 2006;105:127-39.
20. Muratori P, Muratori L, Guidi M, Maccariello S, Pappas G, Ferrari R, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol 2003;132:473-6.
21. Torok HP, Glas J, Gruber R, Brumberger V, Strasser C, Kellner H, et al. Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: increased prevalence of ASCA and pANCA. Digestion 2004;70:49-54.